High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry.
Katharina MayerGjin NdrepepaMira SchroeterChristopher EmmerIsabell BernlochnerStefanie SchüpkeSenta GewaltRaphaela HilzJohn Joseph CoughlanAlp AytekinClarissa HeykenTanja MorathHeribert SchunkertKarl-Ludwig LaugwitzDirk SibbingAdnan KastratiPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
This study did not find an association between HAPR, measured at the time of PCI, and clinical restenosis at 1 year after PCI.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- st elevation myocardial infarction
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- atrial fibrillation
- coronary artery bypass grafting
- low dose
- cardiovascular events
- coronary artery bypass
- type diabetes
- replacement therapy